In briefBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7555.1408 (Published 15 June 2006) Cite this as: BMJ 2006;332:1408
US licenses first cervical cancer vaccine: The US Food and Drug Administration has approved Merck's vaccine Gardasil. The vaccine protects against infection with human papillomavirus types 16 and 18, which cause about 70% of cervical, anal, and genital cancers, and against types 6 and 11, which cause about 90% of genital warts. It has caused controversy because of the recommendation that it …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial